`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`HELSINN HEAL THCARE S.A., et al.,
`
`CIVIL ACTION NO. 12-2867 (MLC)
`
`Plaintiffs,
`
`V.
`
`DR. REDDY'S LABORATORIES, LTD.,
`et al.,
`
`Defendants.
`
`OR DER
`
`PLAINTIFFS, Helsinn Healthcare S.A. and Roche Palo Alto LLC, and Defendants,
`
`Dr. Reddy's Laboratories, Ltd. arnd Dr. Reddy's Laboratories, Inc., asking the Comt to
`
`construe the claim tetm "chelating agent" in United States Patent Number 7,947,724 (see,
`
`~, dkt. entry no. 69, Joint Claim Construction & Preheating Statement at 3-4); and the
`
`Court having conducted a Markman hearing on October 21, 2014 and December 17, 2014
`
`(see dkt. entry nos. 81, 87); and the Court having considered the parties' submissions (see dkt.
`
`entry nos. 73, 74, 76, 77) and ru·gument; and for the reasons stated on the record and in the
`
`forthcoming memorandum opinion:
`
`Dr. Reddy's Laboratories, Ltd., et al.
`V.
`Helsinn Healthcare S.A., et al.
`U.S. Patent No. 8,729,094
`Reddy Exhibit 1045
`
`Exh. 1045
`
`
`
`Case 3:12-cv-02867-MLC-DEA Document 91 Filed 02/19/15 Page 2 of 2 PageiD: 3057
`
`IT IS THEREFORE on this 19th day ofFebruaty, 2015, ORDERED that the
`
`Court constmes the term "chelating agent" to mean a "multi dentate ligand that can form a ring
`
`structure by reacting with a metal ion." A separate memorandum opinion is to be filed. And
`
`it is hereby SO ORDERED.
`
`s/ Mary L. Cooper
`MARY L. COOPER
`United States District Judge
`
`2
`
`Exh. 1045